Geller Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.09M | Sell |
14,455
-2,556
| -15% | -$396K | 0.14% | 41 |
|
|
2024
Q3 | $2.76M | Buy |
17,011
+739
| +5% | +$118K | 0.19% | 34 |
|
|
2024
Q2 | $2.38M | Sell |
16,272
-233
| -1% | -$34.7K | 0.18% | 38 |
|
|
2024
Q1 | $2.61M | Buy |
16,505
+5,576
| +51% | +$888K | 0.21% | 33 |
|
|
2023
Q4 | $1.71M | Sell |
10,929
-612
| -5% | -$93.8K | 0.17% | 37 |
|
|
2023
Q3 | $1.8M | Sell |
11,541
-3,741
| -24% | -$617K | 0.21% | 30 |
|
|
2023
Q2 | $2.53M | Buy |
15,282
+5,253
| +52% | +$848K | 0.32% | 22 |
|
|
2023
Q1 | $1.55M | Buy |
10,029
+828
| +9% | +$134K | 0.23% | 21 |
|
|
2022
Q4 | $1.63M | Buy |
9,201
+222
| +2% | +$38.3K | 0.28% | 14 |
|
|
2022
Q3 | $1.47M | Sell |
8,979
-281
| -3% | -$47.6K | 0.32% | 13 |
|
|
2022
Q2 | $1.64M | Buy |
9,260
+648
| +8% | +$115K | 0.34% | 15 |
|
|
2022
Q1 | $1.53M | Sell |
8,612
-2,114
| -20% | -$360K | 0.28% | 20 |
|
|
2021
Q4 | $1.83M | Buy |
10,726
+67
| +0.6% | +$11K | 0.36% | 17 |
|
|
2021
Q3 | $1.72M | Buy |
10,659
+2,598
| +32% | +$443K | 0.38% | 17 |
|
|
2021
Q2 | $1.33M | Buy |
8,061
+3,090
| +62% | +$512K | 0.29% | 18 |
|
|
2021
Q1 | $817K | Sell |
4,971
-1,045
| -17% | -$169K | 0.19% | 24 |
|
|
2020
Q4 | $1.08M | Hold |
6,016
| – | – | 0.27% | 16 |
|
|
2020
Q3 | $896K | Buy |
6,016
+2,497
| +71% | +$369K | 0.26% | 15 |
|
|
2020
Q2 | $495K | Buy |
3,519
+1,646
| +88% | +$240K | 0.15% | 33 |
|
|
2020
Q1 | $246K | Buy |
1,873
+490
| +35% | +$69.5K | 0.07% | 54 |
|
|
2019
Q4 | $202K | Sell |
1,383
-1,136
| -45% | -$154K | 0.06% | 58 |
|
|
2019
Q3 | $326K | Buy |
2,519
+129
| +5% | +$17K | 0.12% | 37 |
|
|
2019
Q2 | $333K | Sell |
2,390
-22,384
| -90% | -$3.1M | 0.13% | 19 |
|
|
2019
Q1 | $3.46M | Buy |
24,774
+22,834
| +1,177% | +$3.06M | 1.4% | 6 |
|
|
2018
Q4 | $250K | Sell |
1,940
-2,551
| -57% | -$356K | 0.12% | 24 |
|
|
2018
Q3 | $621K | Sell |
4,491
-24,918
| -85% | -$3.31M | 0.37% | 13 |
|
|
2018
Q2 | $3.57M | Buy |
29,409
+795
| +3% | +$99.2K | 1.55% | 5 |
|
|
2018
Q1 | $3.67M | Buy |
28,614
+345
| +1% | +$46.6K | 1.79% | 4 |
|
|
2017
Q4 | $3.95M | Hold |
28,269
| – | – | 1.99% | 4 |
|
|
2017
Q3 | $3.67M | Buy |
28,269
+300
| +1% | +$39.8K | 1.8% | 4 |
|
|
2017
Q2 | $3.7M | Hold |
27,969
| – | – | 1.89% | 4 |
|
|
2017
Q1 | $3.48M | Sell |
27,969
-1,000
| -3% | -$119K | 1.88% | 5 |
|
|
2016
Q4 | $3.34M | Sell |
28,969
-1,787
| -6% | -$206K | 1.98% | 5 |
|
|
2016
Q3 | $3.63M | Buy |
30,756
+1,701
| +6% | +$206K | 2.07% | 4 |
|
|
2016
Q2 | $3.52M | Sell |
29,055
-1,000
| -3% | -$114K | 2.03% | 4 |
|
|
2016
Q1 | $3.25M | Sell |
30,055
-500
| -2% | -$51.8K | 1.94% | 5 |
|
|
2015
Q4 | $3.14M | Buy |
30,555
+500
| +2% | +$50.3K | 1.87% | 4 |
|
|
2015
Q3 | $2.81M | Hold |
30,055
| – | – | 1.79% | 4 |
|
|
2015
Q2 | $2.93M | Hold |
30,055
| – | – | 1.71% | 4 |
|
|
2015
Q1 | $3.02M | Hold |
30,055
| – | – | 1.75% | 4 |
|
|
2014
Q4 | $3.14M | Buy |
30,055
+438
| +1% | +$46.2K | 1.82% | 6 |
|
|
2014
Q3 | $3.16M | Buy |
29,617
+174
| +0.6% | +$18K | 1.78% | 7 |
|
|
2014
Q2 | $3.08M | Sell |
29,443
-92
| -0.3% | -$9.3K | 2.06% | 6 |
|
|
2014
Q1 | $2.9M | Hold |
29,535
| – | – | 1.93% | 6 |
|
|
2013
Q4 | $2.71M | Sell |
29,535
-1,438
| -5% | -$133K | 1.83% | 7 |
|
|
2013
Q3 | $2.69M | Buy |
30,973
+4,120
| +15% | +$370K | 2.02% | 6 |
|
|
2013
Q2 | $2.31M | Buy |
+26,853
| New | +$2.28M | 1.96% | 6 |
|
Other funds holding JNJ
Geller Advisors's JNJ Position: Q4 2024 in Review
Geller Advisors reduced its Johnson & Johnson (JNJ) stake by 15% in Q4 2024, selling an estimated $396K and leaving 14,455 shares worth $2.09M. The position accounts for 0.14% of the portfolio, ranked #41.
Geller Advisors first reported a position in JNJ in Q2 2013 and has held it in 47 quarters since. The position peaked at $3.95M in Q4 2017. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Geller Advisors held 14,455 shares of Johnson & Johnson worth $2.09M as of Q4 2024.
- Geller Advisors sold 2,556 Johnson & Johnson shares in Q4 2024, an estimated $396K.
- Johnson & Johnson made up 0.14% of Geller Advisors's portfolio in Q4 2024, its #41 holding.
- Geller Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 47 quarters since.
- Geller Advisors's Johnson & Johnson position peaked at $3.95M in Q4 2017.
- 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.